Smith & Nephew plc vs United Airlines Holdings Inc — how do they compare? Smith & Nephew plc trades at $27.23 (market cap $11.10B), while United Airlines Holdings Inc trades at $106.62 (market cap $34.87B). The key difference: United Airlines Holdings Inc is far larger — about 3.1× Smith & Nephew plc's market cap, and Smith & Nephew plc pays a 2.95% dividend while United Airlines Holdings Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Smith & Nephew plc for 120 Days and United Airlines Holdings Inc for 46 Days on average.
| SNN | UAL | |
|---|---|---|
Market Cap | $11.10B | $34.87B |
Volume | 1,051,703 | 6,329,678 |
Sector | Health | Industrials |
52-Week High | $37.17 | $136.11 |
52-Week Low | $26.42 | $85.21 |
Typical Hold Time | 120 Days | 46 Days |
Enterprise Value | $14.13B | $51.90B |
Dividend Yield | 2.95% | — |
Signals from Pluang's Aura AI — not financial advice
Smith & Nephew (SNN) trades at $26.89, near its 52-week low, with a bearish technical signal. Revenue grew to $6.16B in 2025, with net income margin improving to 10.08%. Recent product launches, like the EVOS PELVIC System, aim to strengthen its medical technology portfolio, though the stock faces headwinds from analyst downgrades and CFO departure news.
The outlook is cautious; while fundamentals show profitability growth, the stock's proximity to lows and mixed analyst sentiment (26% buy, 65% hold) suggest limited near-term upside. Key risks include competitive pressures and execution challenges, but the stable dividend and institutional interest offer some support for patient investors.
United Airlines (UAL) trades at $110.17, down 1.53% on the day, with a bearish technical signal from moving averages. The stock shows strong fundamentals with a low P/E of 10.32 and consistent earnings beats, including Q2 2026 EPS of $1.99 versus $1.88 expected. Revenue growth has climbed from $45.0B in 2022 to $59.1B in 2025, with net income margin improving to 5.67%. Recent news highlights aggressive customer acquisition efforts targeting Delta's premium flyers.
The outlook is mixed: analyst consensus is strongly bullish with a $158.10 price target and no sell ratings, but technical indicators and rising fuel costs pose near-term risks. Earnings sustainability and market share gains from competitor targeting present upside, while debt levels and operational volatility remain challenges for shareholder value.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →United Airlines is a major U.S. network carrier. United's hubs include San Francisco, Chicago, Houston, Denver, Los Angeles, New York/Newark, and Washington, D.C. United operates a hub-and-spoke system that is more focused on international travel than legacy peers.
Read more on UAL →